Merck buys cancer therapy developer Modifi Biosciences for up to $1.3 billion
(Reuters) – Merck has acquired Modifi Biosciences for as much as $1.3 billion, gaining access...
(Reuters) – Merck has acquired Modifi Biosciences for as much as $1.3 billion, gaining access...
(Reuters) – Apple has sharply scaled back its Vision Pro production since early summer and...
By Christopher Bing and A.J. Vicens (Reuters) -An army of Chinese-controlled social media bots is...
By Ananya Mariam Rajesh (Reuters) – McDonald’s shares fell 4.3% in midday trading on Wednesday,...
By Kannaki Deka (Reuters) -3M Co raised its full-year profit forecast on Tuesday, after strong...
(Reuters) – Industrial paintmaker Sherwin-Williams missed Wall Street estimates for third-quarter profit on Tuesday, hurt...
(Reuters) – The global transition toward electric vehicles will have “far-reaching” impacts on investment, production,...
(Reuters) – Asset management giant BlackRock on Tuesday launched two new exchange-traded funds (ETFs) aimed...
(Reuters) -Walt Disney said on Monday it would appoint a new chief executive officer in...
WASHINGTON (Reuters) – Vice President Kamala Harris and former president Donald Trump remain in a...